The purpose of the study is to compare the efficacy of levosimendan with that of dobutamine in patients with unstable hemodynamics (shock).

Official Title

Efficacy of Levosimendan in the Critically Ill Patients with Unstable Hemodynamics (the LICI study) – A Double Blind Randomized Pilot Study


– Cardiogenic Shock- Septic Shock

Study Type


Study Design

Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study

Further Details

Primary Outcomes: Resolution of shock stateSecondary Outcomes: Change in cardiac functions

Study Start

Study start: October 2004; Expected completion: June 2006

Eligibility & Criteria

Inclusion Criteria:- Reduced left ventricular systolic function – Hypotension – Anuria or oligouria Exclusion Criteria:- Less than 18 years old – Pregnant – Uncorrected valvular stenosis – Hypertrophic obstructive cardiomyopathy (HOCM) – Third degree AV block

Total Enrolment


Contact Details

Intensive Care Unit, Nepean Hospital, Penrith, New South Wales, 2750, Australia; Recruiting:- Anthony S McLean, MD +61-2-47342490 – Stephen J Huang, PhD +61-247342320

All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.